PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

Abuse of Minors in Clinical Studies

A Worldwide Ethical Challenge for the 21st Century

Klaus Rose

$251.95   $201.54

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Ethics International Press Ltd
17 May 2023
"With the emergence of effective drugs and observed drug toxicities in babies, two mantras emerged: that children are therapeutic orphans, and that children are not small adults. US and EU laws demand pediatric studies as a condition for the approval of new drugs in adults. This is called ""Pediatric Drug Development"" (PDD). Although apparently reasonable, there are catches. Children are vulnerable at birth, but they grow and become bodily mature with puberty, well before coming of age. Minors are not another species. The 18th birthday, an administrative/ legal limit, does not correspond to a physiological change. Drugs treat the body, not the legal status. PDD results in pointless studies in bodily mature adolescents, and in exaggerated studies in younger minors. An originally well-intentioned concept results in thousands of questionable studies worldwide.

This book draws attention to conflicts of interest and ethical dilemmas of PDD

and questions its applicability for adolescents and minors that are no longer babies."

By:  
Imprint:   Ethics International Press Ltd
Country of Publication:   United Kingdom
Edition:   New edition
Dimensions:   Height: 234mm,  Width: 156mm, 
ISBN:   9781804411353
ISBN 10:   1804411353
Pages:   164
Publication Date:  
Audience:   College/higher education ,  Further / Higher Education
Format:   Hardback
Publisher's Status:   Active

Klaus Rose was successively Global Head Pediatrics in two large international pharmaceutical companies and is now Chief Executive Officer of klausrose Consulting, Pediatric Drug Development & More, Riehen (BS), Switzerland

See Also